Clinical trials: Orbital Cellulitis

TNF-receptor Associated Periodic Syndromes (TRAPS)

Efficacy and Safety Study of ACZ885 in Patients With Active Recurrent or Chronic TNF-receptor Associated Periodic Syndrome (TRAPS).

• Completed
• Age: 4 years and older
• Phase 2
• Injection or infusion
• Results posted

This trial will assess the safety and efficacy of ACZ885 in patients with active recurrent or chronic TNF-receptor associated periodic syndrome (TRAPS).

Trial name

NCT01242813

Testing

ACZ885

Where

6 sites in Ireland, Italy and 1 more

Volunteers

20 people

Sponsor

Novartis Pharmaceuticals